share_log
Benzinga ·  Apr 29 08:44
Addex Shares Are Trading Lower After the Company Announced the Phase 2 ADX71149 Epilepsy Study Did Not Achieve Statistical Significance for the Primary Endpoint of Time for Patients to Reach Baseline Seizure Count When ADX71149 Was Added to Standard of Care
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment